Literature DB >> 18440840

The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.

Marie E Fondrevelle1, Bernadette Kantelip, Robert E Reiter, Dominique K Chopin, Jean P Thiery, Franck Monnien, Hugues Bittard, Hervé Wallerand.   

Abstract

OBJECTIVES: Twist is considered as transcription factor that regulates epithelial mesenchymal transition (EMT) by at least inhibition of E-cadherin expression. EMT is a key event in the tumor invasion process. The purpose of this study is to investigate the expression of Twist but also those of E- and N-cadherin in human primary bladder tumor and to evaluate its prognostic value. As smoking cigarettes is a strong bladder cancer risk factor, we tried to evaluate the impact of the tobacco status on these molecular abnormalities.
MATERIALS AND METHODS: To delineate on the oncogenic role for Twist in human bladder cancer, we evaluated the E- and N-cadherin but also Twist expression (n = 70) by immunohistochemistry. We evaluated the prognostic value of these expressions. Moreover, we tried to correlate these protein expressions to the smoking status of the patients. Overall survival (OS) and progression-free survival (PFS) were evaluated using the Kaplan-Meier method, and multivariate analysis was performed using the Cox proportional hazard analysis.
RESULTS: Of the 70 bladder tumors, 28 (40%) cases were positive for Twist expression, 16 (23%) cases were negative for E-cadherin expression, and 12 (17%) were positive for N-cadherin expression. When categorized into negative vs. positive expression, Twist was associated with the stage (P = 0.001), the grade (P < 0.001), the progression (P = 0.02), and the E-cadherin expression (P = 0.01). Moreover, positive Twist expression clearly predicted poorer PFS (P = 0.02). In the multivariate analysis, both positive Twist expression and loss of E-cadherin expression were independent prognostic factors for PFS (P = 0.046 and P = 0.001, respectively) and only loss of E-cadherin expression for the OS (P < 0.001). We also demonstrated that almost 60% (16/28) of patients with Twist-positive expression were current smokers at the time of the diagnosis, corroborating the fact that smoking modulates the expression of EMT markers including Twist.
CONCLUSION: Positive Twist expression may be a useful prognostic marker for patients with bladder cancer. Its expression seems to be correlated to the tobacco status of the patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440840     DOI: 10.1016/j.urolonc.2007.12.012

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  35 in total

Review 1.  Immunological basis in the pathogenesis and treatment of bladder cancer.

Authors:  David B Thompson; Larry E Siref; Michael P Feloney; Ralph J Hauke; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-11-13       Impact factor: 4.473

2.  Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.

Authors:  Hui Zhang; Jian Gong; Di Kong; Hong-Yi Liu
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

3.  Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin.

Authors:  Nagaraj S Nagathihalli; Pierre P Massion; Adriana L Gonzalez; Pengcheng Lu; Pran K Datta
Journal:  Mol Cancer Ther       Date:  2012-08-29       Impact factor: 6.261

Review 4.  New and promising strategies in the management of bladder cancer.

Authors:  Andrea B Apolo; Nicholas J Vogelzang; Dan Theodorescu
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

5.  Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.

Authors:  Patrick J Hensley; Daniel Zetter; Craig M Horbinski; Stephen E Strup; Natasha Kyprianou
Journal:  Hum Pathol       Date:  2016-07-08       Impact factor: 3.466

6.  Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.

Authors:  Samia Hussein; Hala Mosaad; Hayam E Rashed; Shimaa Ahmed; Ahmed Ragab; Eman I Ismail
Journal:  Mol Biol Rep       Date:  2017-08-14       Impact factor: 2.316

7.  Epithelial-mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma.

Authors:  Johannes Breyer; Michael Gierth; Sanzhar Shalekenov; Atiqullah Aziz; Julius Schäfer; Maximilian Burger; Stefan Denzinger; Ferdinand Hofstädter; Christian Giedl; Wolfgang Otto
Journal:  World J Urol       Date:  2015-09-22       Impact factor: 4.226

Review 8.  The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

Authors:  Josiah Ochieng; Gladys N Nangami; Olugbemiga Ogunkua; Isabelle R Miousse; Igor Koturbash; Valerie Odero-Marah; Lisa J McCawley; Pratima Nangia-Makker; Nuzhat Ahmed; Yunus Luqmani; Zhenbang Chen; Silvana Papagerakis; Gregory T Wolf; Chenfang Dong; Binhua P Zhou; Dustin G Brown; Anna Maria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Rabeah Al-Temaimi; Fahd Al-Mulla; William H Bisson; Sakina E Eltom
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

9.  Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study.

Authors:  Raffaella Santi; Tommaso Cai; Stefania Nobili; Ilaria Camilla Galli; Andrea Amorosi; Eva Comperat; Gabriella Nesi
Journal:  Virchows Arch       Date:  2018-03-10       Impact factor: 4.064

10.  Expression of transcription factors snail, slug, and twist in human bladder carcinoma.

Authors:  Qinchao Yu; Kejun Zhang; Xinsheng Wang; Xiangping Liu; Zemi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2010-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.